| Davina Roenshi Perera, DO | |
|
1601 Mcdaniel Dr Ste 50, West Chester, PA 19380-7030 | |
| (484) 905-8000 | |
| Not Available |
| Full Name | Davina Roenshi Perera |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 5 Years |
| Location | 1601 Mcdaniel Dr Ste 50, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184287575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OT019623 (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | OS022369 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Bayada Home Health Care, Inc. | Exton, PA | Home health agency |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Chester County Hospital | West chester, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
Alzheimer's disease affects an estimated 5.4 million people in the U.S., some 480,000 of them in California. Nearly half of all people 85 and older will be stricken with the disease. The overall burden of dementia is still higher, with Alzheimer's accounting for only 60 to 80 percent of dementia cases.
The Washington Post reports that "the House's passage Saturday of a sweeping health-care bill has pushed the advertising battle over reform into a new phase, as competing groups have taken to the airwaves to thank or punish Democrats for their votes."
Captozyme, Inc. announced today that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure, an oxalate reducing enzyme, to determine the extent to which Nephure vs. placebo reduces urinary oxalate excretion (mg/24 hour) in healthy subjects who are provided a controlled diet.
› Verified 2 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
Alzheimer's disease affects an estimated 5.4 million people in the U.S., some 480,000 of them in California. Nearly half of all people 85 and older will be stricken with the disease. The overall burden of dementia is still higher, with Alzheimer's accounting for only 60 to 80 percent of dementia cases.
The Washington Post reports that "the House's passage Saturday of a sweeping health-care bill has pushed the advertising battle over reform into a new phase, as competing groups have taken to the airwaves to thank or punish Democrats for their votes."
Captozyme, Inc. announced today that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure, an oxalate reducing enzyme, to determine the extent to which Nephure vs. placebo reduces urinary oxalate excretion (mg/24 hour) in healthy subjects who are provided a controlled diet.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Davina Roenshi Perera, DO 1601 Mcdaniel Dr Ste 50, West Chester, PA 19380-7030 Ph: (484) 905-8000 | Davina Roenshi Perera, DO 1601 Mcdaniel Dr Ste 50, West Chester, PA 19380-7030 Ph: (484) 905-8000 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced at the Global Forum of Maternal and Infant Health, at Barcelona, Spain, NBM200, a non-invasive hemoglobin measurement system for anemia screening and hemorrhage detection. The Company presented results showing that Hb measurements obtained by the NBM200 showed accurate performance compared with invasive point of care devices.
Alzheimer's disease affects an estimated 5.4 million people in the U.S., some 480,000 of them in California. Nearly half of all people 85 and older will be stricken with the disease. The overall burden of dementia is still higher, with Alzheimer's accounting for only 60 to 80 percent of dementia cases.
The Washington Post reports that "the House's passage Saturday of a sweeping health-care bill has pushed the advertising battle over reform into a new phase, as competing groups have taken to the airwaves to thank or punish Democrats for their votes."
Captozyme, Inc. announced today that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure, an oxalate reducing enzyme, to determine the extent to which Nephure vs. placebo reduces urinary oxalate excretion (mg/24 hour) in healthy subjects who are provided a controlled diet.
› Verified 2 days ago
Dr. Paul Debacco, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1161 Mcdermott Dr., Suite 101, West Chester, PA 19380 Phone: 610-701-7011 Fax: 610-429-5199 | |
Miss Sara Elizabeth Sterling, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 Fax: 610-431-5025 | |
Levelle Drose-bigatel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Mcdaniel Dr, Suite 50, West Chester, PA 19380 Phone: 484-905-8000 Fax: 484-905-8005 | |
Dr. George Nicholas Spyropoulos, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1646 W Chester Pike, Suite 12, West Chester, PA 19382 Phone: 610-738-9002 Fax: 610-738-9101 | |
Dr. Louis H Hirshberg, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1114 Lincoln Dr, West Chester, PA 19380 Phone: 610-608-4051 | |
Mary Brigandi, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 Fax: 610-738-2356 | |
Boyd C. Myers, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1240 Wrights Lane, West Chester, PA 19380 Phone: 610-431-1210 Fax: 610-594-2625 |